Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 2981-2987, June 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamasaki, T.
Right arrow Articles by Hanaoka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamasaki, T.
Right arrow Articles by Hanaoka, M.

Immunoregulatory Effects of Interleukin 2 and Interferon on Syngeneic Murine Malignant Glioma-specific Cytotoxic T-Lymphocytes1

Toshiki Yamasaki2, Haruhiko Kikuchi, Junkoh Yamashita, Hajime Handa, Sigeki Kuwata, Masaaki Taguchi, Yuziro Namba and Masao Hanaoka

Department of Neurosurgery, Medical School [T. Y., H. K., J. Y., H. H.], and Department of Pathology, Institute for Virus Research [S. K., M. T., Y. N., M. H.], Kyoto University, Kyoto 606, Japan

The effects of interleukin 2 (IL2) and interferon (IFN) on the generation and lytic activation of syngeneic murine malignant glioma (a methylcholanthrene-induced ependymoblastoma of C57BL/6 mouse origin, 203-glioma)-specific cytotoxic T-lymphocyte (G-CTL) were investigated. The surface marker analysis showed that G-CTLs from both intracranial and s.c. tumor-bearing mice were composed of thymectomy-resistant (mature) Lyt-1-.2.3+ and thymectomy-sensitive (immature) Lyt-1+.2.3+ CTLs, which markedly decreased concurrently with increased intracranial pressure. G-CTLs were confirmed to be activated with target specificity by both factors in a different way. The CTL activation by IL2 (20 units/ml) remained for a longer time, although a lag time of 5 days after initial culture was required. IL2 influenced Lyt-1+.2.3+ CTLs to proliferate and develop the lytic potential. In contrast, even a 3-h incubation with IFN (1000 units/ml) could enhance the cytotoxicity, but the augmenting effects were observed no longer than 5 days later. IFN activated Lyt-1-.2.3+ CTLs and increased their proportion of the total cell population with a simultaneous decrease of Lyt-1+.2.3+ CTLs. Therefore, it was suggested that IL2 may provide a grwoth of CTL populations and that IFN can accelerate recruitment of new effectors, causing activation of the lytic process.

1 Supported by grants from the Department of Neurosurgery, Kyoto University Medical School, Kyoto, Japan.

2 To whom requests for reprints should be addressed, at Department of Neurosurgery, Kyoto University Medical School, Shogoin, 54 Kawahara-cho, Sakyo-ku, Kyoto 606, Japan.

Received 7/ 7/86. Revised 1/20/87. Revised 11/10/87. Revised 2/12/88. Accepted 2/18/88.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Abe, T. Peng, J. Sailors, R. Bucala, and C. N. Metz
Regulation of the CTL Response by Macrophage Migration Inhibitory Factor
J. Immunol., January 15, 2001; 166(2): 747 - 753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.